Biological guidelines

  • Email
  • Help

This section includes the European Medicines Agency's guidelines on biological medicines.

The Agency's Committee for Medicinal Products for Human Use (CHMP) prepares scientific guidelines in consultation with regulatory authorities in the European Union (EU) Member States, to help applicants prepare marketing-authorisation applications for human medicines.

Guidelines reflect a harmonised approach of the EU Member States and the Agency on how to interpret and apply the requirements for the demonstration of quality, safety and efficacy set outin the Community directives.

The Agency strongly encourages applicants and marketing-authorisation holders to follow these guidelines. Applicants need to justify deviations from guidelines fully in their applications at the time of submission. The Agency advises applicants to discuss any proposed deviations with EU regulators during medicine development through scientific advice.

Biological guidelines are provided for:

How useful is this page?

Average rating:

 Based on 32 ratings

Add your rating:

See all ratings
22 ratings
1 ratings
0 ratings
2 ratings
7 ratings